Title : Excision-repair cross-complementing 1 predicts response to cisplatin-based neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Pub. Date : 2009 Nov-Dec

PMID : 21475919






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low excision repair cross-complementing 1 (ERCC1) has been associated with a favorable response to cisplatin (CDDP) in several types of malignancies. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 Low excision repair cross-complementing 1 (ERCC1) has been associated with a favorable response to cisplatin (CDDP) in several types of malignancies. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens